One page, thousands of outlets. See who else covered it.
Rewinding cellular time could address disease and aging, says the Altos Labs co-founder.
We haven't written up this one. Time has the full story — the link below goes straight to it.
Physician and author Dr. Gabrielle Lyon argues doctors have spent fifty years treating longevity as a fat problem, when it's really a muscle problem.
Twenty years after his Nobel-winning discovery, doctors are using Yamanaka's cell-reprogramming breakthrough to treat real patients—and address aging itself.
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping a three-decade effort
“Pretty much every organ system you can think of is touched by the ovaries,” says Francesca Duncan, a reproductive biologist at Northwestern University and Buck Institute for Research on Aging.
The geneticist has played an instrumental role in pushing the idea that existing drugs could be repurposed as longevity-boosting treatments.
Justice, executive director of XPRIZE Healthspan, wants teams to prove human aging can be measurably reversed, not just slowed.
